Status:

COMPLETED

Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study

Lead Sponsor:

GlaxoSmithKline

Conditions:

Pulmonary Disease, Chronic Obstructive

Eligibility:

All Genders

40+ years

Brief Summary

This is a cross-sectional validation study, designed to evaluate the discriminative validity of the Chronic Obstructive Pulmonary Disease Assessment Test translated in a local language in patients wit...

Detailed Description

The Chronic obstructive pulmonary disease Assessment Test is a new questionnaire that has been developed recently to improve communication between doctors and patients. It is known to have good relati...

Eligibility Criteria

Inclusion

  • Subjects eligible for enrolment in the study must meet all of the following criteria:
  • Type of subject: Outpatients
  • Informed consent: Subjects must give their signed and dated written informed consent to participate.
  • Gender: Male or Female
  • Age: 40 years of age or older at a clinic visit
  • COPD diagnosis: Subjects with an established diagnosis of COPD in the past 6 months or before.
  • Tobacco use: Smokers or ex-smokers with a smoking history of more than 10 pack years.

Exclusion

  • Asthma: Subjects with a current diagnosis of asthma. Subjects with a prior history of asthma are eligible if COPD is the current diagnosis.
  • Lung diseases: Subjects with current active respiratory disorders other than COPD, e.g. lung cancer, tuberculosis.
  • Non-compliance: Unable to complete questionnaires

Key Trial Info

Start Date :

December 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2011

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT01424527

Start Date

December 1 2010

End Date

April 1 2011

Last Update

May 16 2017

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

GSK Investigational Site

Anyang-si, South Korea, 431-070

2

GSK Investigational Site

Busan, South Korea

3

GSK Investigational Site

Gyung Gi Do, South Korea

4

GSK Investigational Site

Incheon, South Korea